Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that it has entered into commitment letters relating to its pending acquisition of Allergan’s generic pharmaceuticals business …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that it has successfully filed a Marketing Authorization Application (MAA) with theEuropean Medicines Agency (EMA) for reslizumab. …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is slated to announce second quarter 2015 earnings results on Thursday, July 30, before market open. The …
Youku Tudou Inc (ADR) (NYSE:YOKU) shares slipped more than -6% in pre-market trading down to $18.77 after Chinese shares fell more than 8%.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the launch of generic Axert® (almotriptan malate) tablets, 6.25 mg and 12.
Maxim Group analyst Jason Kolbert weighed in today with some commentary on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) after a U.S.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Microchips Biotech, Inc. today announced that they have entered into a partnership under which the companies will explore innovative …
You have chosen to follow this author. You will receive an email notification when this author publishes a new article.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announces the launch of the generic equivalent of Lomedia® 24 Fe (norethindrone acetate and ethinyl estradiol tablets …
On March 30, Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA) announced they will be acquiring Auspex Pharmaceuticals Inc (NASDAQ:ASPX) in an all-cash transaction valued …
